Variable | Whole Group (n = 182) | Complete Resolution (n = 126) | Persistent CXR Abnormality (n = 56) | p value |
---|---|---|---|---|
Sex (male) | 54% (n = 98) | 51% (n = 64) | 61% (n = 34) | 0.235 |
Age (years) | 58.0 (47–67) | 55.0 (45–64) | 64.0 (54–74) | < 0.001** |
Hospital length of Stay (days) | 9.0 (8–13) | 7.0 (4–12) | 10.5 (7–16) | 0.005** |
Follow-up CXR interval (days) | 80.0 (74–86) | 81.0 (75–86) | 79.0 (72–85) | 0.144 |
Level 2 or 3 Care | 31% (n = 57) | 25% (n = 31) | 46% (n = 26) | 0.003** |
IMV | 8% (n = 15) | 8% (n = 10) | 9% (n = 5) | 0.822 |
CPAP/NIV | 24% (n = 43) | 16% (n = 20) | 41% (n = 23) | < 0.001** |
Oxygen or higher resp. support | 92% (n = 167) | 90% (n = 114) | 95% (n = 53) | 0.345 |
BAME | 27% (n = 47) | 29% (n = 35) | 23% (n = 12) | 0.407 |
Obesity (BMI > 30 kg/m 2 ) | 40% (n = 72) | 42% (n = 53) | 34% (n = 19) | 0.300 |
Ever smoker | 44% (n = 80) | 39% (n = 49) | 55% (n = 31) | 0.038* |
Hypertension | 23% (n = 42) | 25% (n = 31) | 20% (n = 11) | 0.464 |
Diabetes Melitus (all types) | 20% (n = 37) | 22% (n = 28) | 16% (n = 9) | 0.341 |
Baseline LDH U/L^ | 643 (506–854) | 626 (501–830) | 667 (535–959) | 0.240 |
Follow-up LDH U/L^ | 387 (348–449) | 379 (329–443) | 407 (367–456) | 0.032* |